Clinical Trials Arena on MSN
AbbVie’s skin disease drug posts Phase III win as market competition heats up
This late-stage readout comes as companies explore the potential of novel mechanisms of action in HS.
3don MSN
AbbVie’s skin disease drug hits phase 3 goal, but efficacy falls short of benchmarks: analyst
AbbVie Inc. ABBV on Thursday shared topline results from its Phase 3 INTREPID study evaluating lutikizumab in adults and ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
The American Academy of Dermatology and Hidradenitis Suppurativa Foundation issued joint clinical guidelines for hidradenitis suppurativa, a condition that affects up to 1.5% of the global population.
ROSEMONT, Ill. (Oct. 20, 2026) — Over 3 million people have been diagnosed with hidradenitis suppurativa (HS) in the United States and today, the American Academy of Dermatology (AAD) and the ...
What’s your type? Skin type, that is! The five main skin types are normal, dry, oily, combination (dry and oily), and sensitive. Understanding your skin type helps you work with it better so you can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results